1Anderson G H, Blakeman N, Streeten D H. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens, 1994, 12.. 609-615.
2Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res, 2004, 27: 193-202.
3Sinclair A M, Isles C G, Brown I, et al. Secondary hypertension in a blood pressure clinic. Arch Intern Med, 1987, 147: 1289-1293.
4Platts J K, Drew P J, Harvey J N. Death from phaeochromocytoma: lessons from a post-mortem survey. J R Coll Physicians Lond, 1995, 29: 299-306.
5McNeil A R, Blok B H, Koelmeyer T D, et al. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med, 2000, 30:648-652.
6Lenders J W, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet, 2005, 366: 665-675.
7Schurmeyer T H, Engeroff B, Dralle H, et al. Cardiological effects of catecholamine-secreting tumours. EurJ Clin Invest, 1997, 27: 189-195.
8Liao W B, Liu C F, Chiang C W, et al. Cardiovascular manifestations of pheochromocytoma. Am J Emerg Med, 2000,18: 622-625.
9Brouwers F M, Lenders J W, Eisenhofer G, et al. Pheoehromoeytoma as an endocrine emergency. Rev Endocr Metab Disord, 2003, 4: 121-128.
10Baguet J P, Hammer L, Mazzuco T L, et al. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol, 2004, 150: 681-686.
9Raber W,Raffesberg W,Bischof M,et al.Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma[J].Arch Intern Med,2000,160(19):2957-2963.
10Dougald C. MacGillivray MD,Giles F. Whalen MD,Carl D. Malchoff MD, PhD,Daniel S. Oppenheim MD, PhD,Steven J. Shichman MD.Laparoscopic resection of large adrenal tumors[J].Annals of Surgical Oncology.2002(5)
